{"database": "lobbying", "table": "lobbying_activities", "rows": [[1989725, "f355b10c-bac1-4a48-a6a6-6a103e0fbc28", "Q2", "MAGNET STRATEGY GROUP", 401104125, "MEDICAGO INC.", 2017, "second_quarter", "MED", "Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease.", "HOUSE OF REPRESENTATIVES,SENATE", 7000, null, 0, 0, "2017-07-17T15:07:33.333000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1989725"], "units": {}, "query_ms": 0.5683070048689842, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}